AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
This has with reference to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 kindly note that Mr. Adhish P. Patil, Chief Financial Officer of the Company had attended 'Ashwamedh, Elara India Virtual Dialogue 2020' on 1st and 2nd September, 2020.